ID   LRRK1_HUMAN             Reviewed;        2015 AA.
AC   Q38SD2; Q6NVH5; Q6NYC0; Q6ZNL9; Q6ZNM9; Q96JN5; Q9H5S3;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   12-OCT-2022, entry version 161.
DE   RecName: Full=Leucine-rich repeat serine/threonine-protein kinase 1;
DE            EC=2.7.11.1;
GN   Name=LRRK1 {ECO:0000312|EMBL:AAY67799.1};
GN   Synonyms=KIAA1790 {ECO:0000312|EMBL:BAB47419.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAH68080.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1576-2015 (ISOFORM 1).
RC   TISSUE=Pancreas {ECO:0000312|EMBL:AAH68080.1}, and Skin
RC   {ECO:0000312|EMBL:AAH66655.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAY67799.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 28-2015 (ISOFORM 1), FUNCTION, ACTIVITY
RP   REGULATION, SUBCELLULAR LOCATION, AUTOPHOSPHORYLATION, GTP-BINDING, AND
RP   MUTAGENESIS OF LYS-651; LYS-746; PHE-1022; LYS-1270 AND ILE-1412.
RX   PubMed=16243488; DOI=10.1016/j.cellsig.2005.08.015;
RA   Korr D., Toschi L., Donner P., Pohlenz H.-P., Kreft B., Weiss B.;
RT   "LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc
RT   domain.";
RL   Cell. Signal. 18:910-920(2006).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:BAC85472.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 145-364 AND 905-2015 (ISOFORM 1).
RC   TISSUE=Lung {ECO:0000312|EMBL:BAB15547.1}, Macrophage
RC   {ECO:0000312|EMBL:BAC85472.1}, and Spleen
RC   {ECO:0000312|EMBL:BAC85125.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:BAB47419.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 646-2015 (ISOFORM 1).
RC   TISSUE=Brain {ECO:0000312|EMBL:BAB47419.1};
RX   PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [6]
RP   HOMODIMERIZATION, AND LACK OF AUTOPHOSPHORYLATION.
RX   PubMed=22952686; DOI=10.1371/journal.pone.0043472;
RA   Civiero L., Vancraenenbroeck R., Belluzzi E., Beilina A., Lobbestael E.,
RA   Reyniers L., Gao F., Micetic I., De Maeyer M., Bubacco L., Baekelandt V.,
RA   Cookson M.R., Greggio E., Taymans J.M.;
RT   "Biochemical characterization of highly purified leucine-rich repeat
RT   kinases 1 and 2 demonstrates formation of homodimers.";
RL   PLoS ONE 7:E43472-E43472(2012).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-1803; PHE-1824; ASN-1847 AND GLY-1927.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [8]
RP   INTERACTION WITH CSK.
RX   PubMed=23526378; DOI=10.1002/jbmr.1935;
RA   Xing W., Liu J., Cheng S., Vogel P., Mohan S., Brommage R.;
RT   "Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich
RT   repeat kinase 2 in mice causes severe osteopetrosis.";
RL   J. Bone Miner. Res. 28:1962-1974(2013).
RN   [9]
RP   INVOLVEMENT IN OSMD.
RX   PubMed=27055475; DOI=10.1136/jmedgenet-2016-103756;
RA   Iida A., Xing W., Docx M.K., Nakashima T., Wang Z., Kimizuka M.,
RA   Van Hul W., Rating D., Spranger J., Ohashi H., Miyake N., Matsumoto N.,
RA   Mohan S., Nishimura G., Mortier G., Ikegawa S.;
RT   "Identification of biallelic LRRK1 mutations in osteosclerotic metaphyseal
RT   dysplasia and evidence for locus heterogeneity.";
RL   J. Med. Genet. 53:568-574(2016).
RN   [10]
RP   INVOLVEMENT IN OSMD.
RX   PubMed=27829680; DOI=10.1038/jhg.2016.136;
RA   Guo L., Girisha K.M., Iida A., Hebbar M., Shukla A., Shah H., Nishimura G.,
RA   Matsumoto N., Nismath S., Miyake N., Ikegawa S.;
RT   "Identification of a novel LRRK1 mutation in a family with osteosclerotic
RT   metaphyseal dysplasia.";
RL   J. Hum. Genet. 62:437-441(2017).
RN   [11]
RP   INVOLVEMENT IN OSMD, AND VARIANT OSMD 929-GLU--ARG-2015 DEL.
RX   PubMed=31571209; DOI=10.1111/ahg.12352;
RA   Miryounesi M., Nikfar A., Changi-Ashtiani M., Shahrooei M.,
RA   Dinmohammadi H., Shahani T., Zarvandi S., Bahrami T., Momenilandi M.,
RA   Rokni-Zadeh H.;
RT   "A novel homozygous LRRK1 stop gain mutation in a patient suspected with
RT   osteosclerotic metaphyseal dysplasia.";
RL   Ann. Hum. Genet. 84:102-106(2020).
RN   [12]
RP   INVOLVEMENT IN OSMD.
RX   PubMed=32119750; DOI=10.1002/jbmr.3995;
RA   Howaldt A., Hennig A.F., Rolvien T., Roessler U., Stelzer N., Knaus A.,
RA   Boettger S., Zustin J., Geissler S., Oheim R., Amling M., Howaldt H.P.,
RA   Kornak U.;
RT   "Adult Osteosclerotic Metaphyseal Dysplasia With Progressive Osteonecrosis
RT   of the Jaws and Abnormal Bone Resorption Pattern Due to a LRRK1 Splice Site
RT   Mutation.";
RL   J. Bone Miner. Res. 35:1322-1332(2020).
CC   -!- FUNCTION: Plays a role in the negative regulation of bone mass, acting
CC       through the maturation of osteoclasts. {ECO:0000250|UniProtKB:Q3UHC2}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:16243488};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:16243488};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:16243488};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:16243488};
CC   -!- ACTIVITY REGULATION: Binding of GTP stimulates kinase activity.
CC       {ECO:0000269|PubMed:16243488}.
CC   -!- SUBUNIT: Homodimer (PubMed:22952686). Interacts with CSK
CC       (PubMed:23526378). {ECO:0000269|PubMed:22952686,
CC       ECO:0000269|PubMed:23526378}.
CC   -!- INTERACTION:
CC       Q38SD2; P00519: ABL1; NbExp=3; IntAct=EBI-1050422, EBI-375543;
CC       Q38SD2; Q9UL15: BAG5; NbExp=3; IntAct=EBI-1050422, EBI-356517;
CC       Q38SD2; P53355: DAPK1; NbExp=2; IntAct=EBI-1050422, EBI-358616;
CC       Q38SD2; P00533: EGFR; NbExp=2; IntAct=EBI-1050422, EBI-297353;
CC       Q38SD2; Q38SD2: LRRK1; NbExp=3; IntAct=EBI-1050422, EBI-1050422;
CC       Q38SD2; Q5S007: LRRK2; NbExp=5; IntAct=EBI-1050422, EBI-5323863;
CC       Q38SD2-1; Q96SN8: CDK5RAP2; NbExp=2; IntAct=EBI-16165296, EBI-308374;
CC       Q38SD2-2; P06756: ITGAV; NbExp=3; IntAct=EBI-25929016, EBI-298282;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16243488}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q38SD2-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:15489334};
CC         IsoId=Q38SD2-2; Sequence=VSP_040119, VSP_040120;
CC   -!- DISEASE: Osteosclerotic metaphyseal dysplasia (OSMD) [MIM:615198]: An
CC       autosomal recessive skeletal dysplasia characterized by osteosclerosis
CC       at multiple skeletal sites, predominantly at the metaphyses of the long
CC       bones and vertebral bodies. {ECO:0000269|PubMed:27055475,
CC       ECO:0000269|PubMed:27829680, ECO:0000269|PubMed:31571209,
CC       ECO:0000269|PubMed:32119750}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. ROCO subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAY67799.1; Type=Miscellaneous discrepancy; Note=The cDNA contains a duplication of exon 3.; Evidence={ECO:0000305};
CC       Sequence=BAB15547.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC85472.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC090907; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC066655; AAH66655.1; -; mRNA.
DR   EMBL; BC068080; AAH68080.1; -; mRNA.
DR   EMBL; DQ013130; AAY67799.1; ALT_SEQ; mRNA.
DR   EMBL; AK026772; BAB15547.1; ALT_INIT; mRNA.
DR   EMBL; AK130975; BAC85472.1; ALT_INIT; mRNA.
DR   EMBL; AK131075; BAC85125.1; -; mRNA.
DR   EMBL; AB058693; BAB47419.1; -; mRNA.
DR   CCDS; CCDS42086.1; -. [Q38SD2-1]
DR   RefSeq; NP_078928.3; NM_024652.5. [Q38SD2-1]
DR   RefSeq; XP_011520314.1; XM_011522012.2. [Q38SD2-1]
DR   RefSeq; XP_011520315.1; XM_011522013.2. [Q38SD2-1]
DR   AlphaFoldDB; Q38SD2; -.
DR   SMR; Q38SD2; -.
DR   BioGRID; 122823; 89.
DR   DIP; DIP-50235N; -.
DR   IntAct; Q38SD2; 96.
DR   STRING; 9606.ENSP00000373600; -.
DR   iPTMnet; Q38SD2; -.
DR   PhosphoSitePlus; Q38SD2; -.
DR   BioMuta; LRRK1; -.
DR   DMDM; 313104220; -.
DR   EPD; Q38SD2; -.
DR   jPOST; Q38SD2; -.
DR   MassIVE; Q38SD2; -.
DR   MaxQB; Q38SD2; -.
DR   PaxDb; Q38SD2; -.
DR   PeptideAtlas; Q38SD2; -.
DR   PRIDE; Q38SD2; -.
DR   ProteomicsDB; 61644; -. [Q38SD2-1]
DR   ProteomicsDB; 61645; -. [Q38SD2-2]
DR   ABCD; Q38SD2; 2 sequenced antibodies.
DR   Antibodypedia; 2085; 202 antibodies from 28 providers.
DR   DNASU; 79705; -.
DR   Ensembl; ENST00000388948.8; ENSP00000373600.3; ENSG00000154237.13. [Q38SD2-1]
DR   Ensembl; ENST00000532029.6; ENSP00000433268.2; ENSG00000154237.13. [Q38SD2-2]
DR   GeneID; 79705; -.
DR   KEGG; hsa:79705; -.
DR   MANE-Select; ENST00000388948.8; ENSP00000373600.3; NM_024652.6; NP_078928.3.
DR   UCSC; uc002bwq.2; human. [Q38SD2-1]
DR   CTD; 79705; -.
DR   DisGeNET; 79705; -.
DR   GeneCards; LRRK1; -.
DR   HGNC; HGNC:18608; LRRK1.
DR   HPA; ENSG00000154237; Low tissue specificity.
DR   MalaCards; LRRK1; -.
DR   MIM; 610986; gene.
DR   MIM; 615198; phenotype.
DR   neXtProt; NX_Q38SD2; -.
DR   OpenTargets; ENSG00000154237; -.
DR   Orphanet; 500548; Osteosclerotic metaphyseal dysplasia.
DR   PharmGKB; PA134892363; -.
DR   VEuPathDB; HostDB:ENSG00000154237; -.
DR   eggNOG; KOG0192; Eukaryota.
DR   eggNOG; KOG0619; Eukaryota.
DR   GeneTree; ENSGT00940000160363; -.
DR   HOGENOM; CLU_001731_0_0_1; -.
DR   InParanoid; Q38SD2; -.
DR   OMA; CHICAAA; -.
DR   OrthoDB; 14978at2759; -.
DR   PhylomeDB; Q38SD2; -.
DR   TreeFam; TF313679; -.
DR   PathwayCommons; Q38SD2; -.
DR   SignaLink; Q38SD2; -.
DR   SIGNOR; Q38SD2; -.
DR   BioGRID-ORCS; 79705; 13 hits in 1103 CRISPR screens.
DR   ChiTaRS; LRRK1; human.
DR   GeneWiki; LRRK1; -.
DR   GenomeRNAi; 79705; -.
DR   Pharos; Q38SD2; Tbio.
DR   PRO; PR:Q38SD2; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q38SD2; protein.
DR   Bgee; ENSG00000154237; Expressed in lymph node and 134 other tissues.
DR   ExpressionAtlas; Q38SD2; baseline and differential.
DR   Genevisible; Q38SD2; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IBA:GO_Central.
DR   GO; GO:0045453; P:bone resorption; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:0036035; P:osteoclast development; IEA:Ensembl.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IGI:ParkinsonsUK-UCL.
DR   GO; GO:1902533; P:positive regulation of intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   Gene3D; 1.25.40.20; -; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   Gene3D; 3.80.10.10; -; 3.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR032171; COR.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR020859; ROC_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF16095; COR; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00248; ANK; 3.
DR   SMART; SM00369; LRR_TYP; 8.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS51450; LRR; 11.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS51424; ROC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ANK repeat; ATP-binding; Cytoplasm; Disease variant;
KW   GTP-binding; Kinase; Leucine-rich repeat; Magnesium; Manganese;
KW   Metal-binding; Nucleotide-binding; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..2015
FT                   /note="Leucine-rich repeat serine/threonine-protein kinase
FT                   1"
FT                   /id="PRO_0000233377"
FT   REPEAT          86..116
FT                   /note="ANK 1"
FT   REPEAT          119..148
FT                   /note="ANK 2"
FT   REPEAT          152..182
FT                   /note="ANK 3"
FT   REPEAT          193..222
FT                   /note="ANK 4"
FT   REPEAT          279..300
FT                   /note="LRR 1"
FT   REPEAT          303..324
FT                   /note="LRR 2"
FT   REPEAT          330..351
FT                   /note="LRR 3"
FT   REPEAT          353..374
FT                   /note="LRR 4"
FT   REPEAT          381..402
FT                   /note="LRR 5"
FT   REPEAT          405..426
FT                   /note="LRR 6"
FT   REPEAT          427..447
FT                   /note="LRR 7"
FT   REPEAT          451..472
FT                   /note="LRR 8"
FT   REPEAT          474..495
FT                   /note="LRR 9"
FT   REPEAT          498..519
FT                   /note="LRR 10"
FT   REPEAT          549..570
FT                   /note="LRR 11"
FT   REPEAT          572..594
FT                   /note="LRR 12"
FT   REPEAT          596..617
FT                   /note="LRR 13"
FT   DOMAIN          632..826
FT                   /note="Roc"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00758"
FT   DOMAIN          1242..1525
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          26..56
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1788..1810
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1841..1899
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1841..1874
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1386
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         1248..1256
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         1270
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VAR_SEQ         255..264
FT                   /note="ALRVKWSHLR -> VSSHCLWSVF (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040119"
FT   VAR_SEQ         265..2015
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040120"
FT   VARIANT         929..2015
FT                   /note="Missing (in OSMD)"
FT                   /evidence="ECO:0000269|PubMed:31571209"
FT                   /id="VAR_086690"
FT   VARIANT         1803
FT                   /note="A -> T"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040674"
FT   VARIANT         1824
FT                   /note="L -> F"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040675"
FT   VARIANT         1847
FT                   /note="S -> N"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040676"
FT   VARIANT         1927
FT                   /note="D -> G"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040677"
FT   MUTAGEN         651
FT                   /note="K->A: Loss of GTP/GDP-binding."
FT                   /evidence="ECO:0000269|PubMed:16243488"
FT   MUTAGEN         746
FT                   /note="K->G: No effect on GTP-binding but reduction in
FT                   subsequent stimulation of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:16243488"
FT   MUTAGEN         1022
FT                   /note="F->C: No effect on GTP-binding but loss of
FT                   subsequent stimulation of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:16243488"
FT   MUTAGEN         1270
FT                   /note="K->W: Loss of autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:16243488"
FT   MUTAGEN         1412
FT                   /note="I->T: No effect on GTP-binding but reduction in
FT                   subsequent stimulation of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:16243488"
FT   CONFLICT        203
FT                   /note="K -> R (in Ref. 4; BAC85472)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1938
FT                   /note="G -> E (in Ref. 2; AAH66655 and 5; BAB47419)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2015 AA;  225393 MW;  38E77EDC7C84583B CRC64;
     MAGMSQRPPS MYWCVGPEES AVCPERAMET LNGAGDTGGK PSTRGGDPAA RSRRTEGIRA
     AYRRGDRGGA RDLLEEACDQ CASQLEKGQL LSIPAAYGDL EMVRYLLSKR LVELPTEPTD
     DNPAVVAAYF GHTAVVQELL ESLPGPCSPQ RLLNWMLALA CQRGHLGVVK LLVLTHGADP
     ESYAVRKNEF PVIVRLPLYA AIKSGNEDIA IFLLRHGAYF CSYILLDSPD PSKHLLRKYF
     IEASPLPSSY PGKTALRVKW SHLRLPWVDL DWLIDISCQI TELDLSANCL ATLPSVIPWG
     LINLRKLNLS DNHLGELPGV QSSDEIICSR LLEIDISSNK LSHLPPGFLH LSKLQKLTAS
     KNCLEKLFEE ENATNWIGLR KLQELDISDN KLTELPALFL HSFKSLNSLN VSRNNLKVFP
     DPWACPLKCC KASRNALECL PDKMAVFWKN HLKDVDFSEN ALKEVPLGLF QLDALMFLRL
     QGNQLAALPP QEKWTCRQLK TLDLSRNQLG KNEDGLKTKR IAFFTTRGRQ RSGTEAASVL
     EFPAFLSESL EVLCLNDNHL DTVPPSVCLL KSLSELYLGN NPGLRELPPE LGQLGNLWQL
     DTEDLTISNV PAEIQKEGPK AMLSYLRAQL RKAEKCKLMK MIIVGPPRQG KSTLLEILQT
     GRAPQVVHGE ATIRTTKWEL QRPAGSRAKV ESVEFNVWDI GGPASMATVN QCFFTDKALY
     VVVWNLALGE EAVANLQFWL LNIEAKAPNA VVLVVGTHLD LIEAKFRVER IATLRAYVLA
     LCRSPSGSRA TGFPDITFKH LHEISCKSLE GQEGLRQLIF HVTCSMKDVG STIGCQRLAG
     RLIPRSYLSL QEAVLAEQQR RSRDDDVQYL TDRQLEQLVE QTPDNDIKDY EDLQSAISFL
     IETGTLLHFP DTSHGLRNLY FLDPIWLSEC LQRIFNIKGS RSVAKNGVIR AEDLRMLLVG
     TGFTQQTEEQ YFQFLAKFEI ALPVANDSYL LPHLLPSKPG LDTHGMRHPT ANTIQRVFKM
     SFVPVGFWQR FIARMLISLA EMDLQLFENK KNTKSRNRKV TIYSFTGNQR NRCSTFRVKR
     NQTIYWQEGL LVTFDGGYLS VESSDVNWKK KKSGGMKIVC QSEVRDFSAM AFITDHVNSL
     IDQWFPALTA TESDGTPLME QYVPCPVCET AWAQHTDPSE KSEDVQYFDM EDCVLTAIER
     DFISCPRHPD LPVPLQELVP ELFMTDFPAR LFLENSKLEH SEDEGSVLGQ GGSGTVIYRA
     RYQGQPVAVK RFHIKKFKNF ANVPADTMLR HLRATDAMKN FSEFRQEASM LHALQHPCIV
     ALIGISIHPL CFALELAPLS SLNTVLSENA RDSSFIPLGH MLTQKIAYQI ASGLAYLHKK
     NIIFCDLKSD NILVWSLDVK EHINIKLSDY GISRQSFHEG ALGVEGTPGY QAPEIRPRIV
     YDEKVDMFSY GMVLYELLSG QRPALGHHQL QIAKKLSKGI RPVLGQPEEV QFRRLQALMM
     ECWDTKPEKR PLALSVVSQM KDPTFATFMY ELCCGKQTAF FSSQGQEYTV VFWDGKEESR
     NYTVVNTEKG LMEVQRMCCP GMKVSCQLQV QRSLWTATED QKIYIYTLKG MCPLNTPQQA
     LDTPAVVTCF LAVPVIKKNS YLVLAGLADG LVAVFPVVRG TPKDSCSYLC SHTANRSKFS
     IADEDARQNP YPVKAMEVVN SGSEVWYSNG PGLLVIDCAS LEICRRLEPY MAPSMVTSVV
     CSSEGRGEEV VWCLDDKANS LVMYHSTTYQ LCARYFCGVP SPLRDMFPVR PLDTEPPAAS
     HTANPKVPEG DSIADVSIMY SEELGTQILI HQESLTDYCS MSSYSSSPPR QAARSPSSLP
     SSPASSSSVP FSTDCEDSDM LHTPGAASDR SEHDLTPMDG ETFSQHLQAV KILAVRDLIW
     VPRRGGDVIV IGLEKDSGAQ RGRVIAVLKA RELTPHGVLV DAAVVAKDTV VCTFENENTE
     WCLAVWRGWG AREFDIFYQS YEELGRLEAC TRKRR
//
